SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
Status:
Terminated
Trial end date:
2014-03-27
Target enrollment:
Participant gender:
Summary
This study is an optional continuation of previous short-term adult major depressive disorder
(MDD) augmentation studies. Patients may only take part in this long-term, open-label
research study if they completed a previous double-blind MDD augmentation study using SPD489.